Why I Wouldn't Touch IonQ, Even With Quantum Computing Stocks Soaring
IonQ is growing blisteringly fast.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.
- AbbVie relies on three key distributors for U.S. sales
- Johnson & Johnson operates diversified medical conglomerate
- Johnson & Johnson offers stable dividends and broader sector exposure
The Surprising Way Working After Your Full Retirement Age (FRA) Could Cost You Social Security Benefits
Key PointsWorking and claiming Social Security could cause you to owe more Social Security benefit taxes.
Is D-Wave Quantum a Buy?
Key PointsD-Wave's annealing systems are already running production workloads at companies like AT&T -- a commercial milestone no other quantum computing company has reached.
